These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6139836)

  • 21. The changes of aggregability of blood platelets in schizophrenia.
    Dietrich-Muszalska A; Olas B
    World J Biol Psychiatry; 2009; 10(2):171-6. PubMed ID: 19514099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Kinetics of the cellular response: the phenomenon of supercooperativity in platelet aggregation].
    Vrzheshch PV; Tatarintsev AV; Ershov DE; Fedorov NA; Zaĭtsev SV; Varfolomeev SD
    Dokl Akad Nauk SSSR; 1989; 307(2):477-80. PubMed ID: 2509180
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of aspirin and prostaglandin E2 on secondary phase aggregation responses of schizophrenic patients treated with chlorpromazine.
    Boullin DJ; Orr MW
    Br J Clin Pharmacol; 1976 Oct; 3(5):929-33. PubMed ID: 973989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of the inhibitory action of prostaglandin E1 on platelet aggregation in rats: a study with ticlopidine, aspirin, dipyridamole and sulfinpyrazone.
    Tuong CC; Ferrand C; Aubert D; Loubrie JC; Tuong A
    Biochem Pharmacol; 1982 Mar; 31(6):1147-50. PubMed ID: 7200772
    [No Abstract]   [Full Text] [Related]  

  • 25. Dihomo-gamma-linolenate suppresses platelet aggregation when administered in vitro or in vivo.
    Willis AL; Comai K; Kuhn DC; Paulsrud J
    Prostaglandins; 1974 Dec; 8(6):509-19. PubMed ID: 4462154
    [No Abstract]   [Full Text] [Related]  

  • 26. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
    Patscheke H; Stegmeier K
    Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The reliability of 5-hydroxytryptamine induced platelet aggregation responses in schizophrenic patients treated with neuroleptic drugs.
    Knox JM; Orr MW; Allen R; Gelder MG; Grahame-Smith DG
    Br J Clin Pharmacol; 1981 Mar; 11(3):261-3. PubMed ID: 6111334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological evaluation of ONO 1206, a prostaglandin E1 derivative, as antianginal agent.
    Tsuboi T; Hatano N; Nakatsuji K; Fujitani B; Yoshida K; Shimizu M; Kawasaki A; Sakata M; Tsuboshima M
    Adv Prostaglandin Thromboxane Res; 1980; 6():347-9. PubMed ID: 7386273
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of OP 1206, a prostaglandin E1 derivative, on guinea-pig platelet functions.
    Tsuboi T; Fujitani B; Maeda J; Yoshida K; Shimizu M; Kawasaki A; Okegawa T; Tsuboshima M
    Thromb Res; 1980 Dec 1-15; 20(5-6):573-80. PubMed ID: 7233385
    [No Abstract]   [Full Text] [Related]  

  • 30. Platelet aggregation, sensitivity to prostaglandin E1 and thromboxane A2 release in recombinant hirudin- and heparin-anticoagulated blood.
    Viigimaa M; Tsikas D; Frölich JC
    Blood Coagul Fibrinolysis; 1996 Mar; 7(2):259-61. PubMed ID: 8735834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malondialdehyde formation as an indicator of prostaglandin production by human platelets.
    Smith JB; Ingerman CM; Silver MJ
    J Lab Clin Med; 1976 Jul; 88(1):167-72. PubMed ID: 932533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of various stimulators on cyclooxygenase activity, platelet aggregation and TxB2 synthesis after using a platelet inhibitor (Aspro Clear) in vivo and in vitro].
    Gorczynska E; James M; Wegrzynowicz R; Masiak M
    Wiad Lek; 1985 Jul; 38(13):920-5. PubMed ID: 3933184
    [No Abstract]   [Full Text] [Related]  

  • 33. Collagen-induced platelet aggregation: evidence of several mechanisms for the induction of platelet release by collagen.
    Nyman D
    Thromb Res; 1977 May; 10(5):743-51. PubMed ID: 882960
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of Soviet-made prostaglandin E1 on the aggregation of thrombocytes and erythrocytes].
    Lakin KM; Makarov VA; Ovnatanova MS; Azhgikhin IS
    Farmakol Toksikol; 1976; 39(4):436-40. PubMed ID: 1027569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of platelet aggregation by novel benzoylpyrrole derivatives.
    Kurozumi S; Ohtsu A; Hoshina K; Jimba M; Komoriya K; Naruchi T; Wakabayashi T; Hashimoto Y; Ishimoto S
    Adv Prostaglandin Thromboxane Res; 1980; 6():305-7. PubMed ID: 7386272
    [No Abstract]   [Full Text] [Related]  

  • 36. Identification of platelet inhibitor present in the melon (Cucurbitacea cucumis melo).
    Altman R; Rouvier J; Weisenberger H
    Thromb Haemost; 1985 Jun; 53(3):312-3. PubMed ID: 3931281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of some pyrimido-pyrimidine derivatives on blood coagulation and platelet aggregation.
    Bédi J; Blaskó G; Pálos LA
    Arzneimittelforschung; 1979; 29(9):1405-8. PubMed ID: 583250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cadmium-induced platelet hypersensitivity to aggregating agents.
    Caprino L; Togna G; Togna AR
    Pharmacol Res Commun; 1979 Oct; 11(9):731-7. PubMed ID: 231263
    [No Abstract]   [Full Text] [Related]  

  • 39. Potentiation of platelet responses in vitro by feline infectious peritonitis virus.
    Boudreaux MK; Weiss RC; Toivio-Kinnucan M; Spano JS
    Vet Pathol; 1990 Jul; 27(4):261-8. PubMed ID: 2144930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of thromboxane A2.
    Ambler J; Birch J; Maguire ED; Wallis RB
    Adv Exp Med Biol; 1985; 192():293-308. PubMed ID: 2939695
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.